Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Cytomegalovirus Infection

Free Subscription Articles published in PLoS One Retrieve available abstracts of 64 articles: HTML format Text format

Single Articles

January 2019
1. GRIFFITHS GO, Cowan RA, Grigor KM, Uscinska BM, et al
   BA08: An open-label, single-arm, non-randomised, phase 2 trial of cisplatin, methotrexate and vinblastine (CMV) for pure squamous cell cancer of the urinary tract.
   PLoS One. 2019;14:e0210785.
   PubMed     Text format     Abstract available
   
   
   
2. HANSEN SG, Womack J, Scholz I, Renner A, et al
   Cytomegalovirus vectors expressing Plasmodium knowlesi antigens induce immune responses that delay parasitemia upon sporozoite challenge.
   PLoS One. 2019;14:e0210252.
   PubMed     Text format     Abstract available
   
   
   
3. LUMLEY S, Green C, Rafferty H, Smith C, et al
   Cytomegalovirus viral load parameters associated with earlier initiation of pre-emptive therapy after solid organ transplantation.
   PLoS One. 2019;14:e0210420.
   PubMed     Text format     Abstract available
   
   
   
4. VARANASI PR, Ogonek J, Luther S, Dammann E, et al
   Cytomegalovirus-specific CD8+ T-cells are associated with a reduced incidence of early relapse after allogeneic stem cell transplantation.
   PLoS One. 2019;14:e0213739.
   PubMed     Text format     Abstract available
   
   
   
5. CHOI JA, Kim JE, Ju HH, Lee J, et al
   The effects of losartan on cytomegalovirus infection in human trabecular meshwork cells.
   PLoS One. 2019;14:e0218471.
   PubMed     Text format     Abstract available
   
   
   
6. MORISHITA M, Sada KE, Matsumoto Y, Hayashi K, et al
   Risk factors for cytomegalovirus infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
   PLoS One. 2019;14:e0218705.
   PubMed     Text format     Abstract available
   
   
   
7. LOPEZ-ALADID R, Guiu A, Mosquera MM, Lopez-Medrano F, et al
   Improvement in detecting cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance using next generation sequencing.
   PLoS One. 2019;14:e0219701.
   PubMed     Text format     Abstract available
   
   
   
8. CHOI JA, Kim JE, Ju HH, Lee J, et al
   Correction: The effects of losartan on cytomegalovirus infection in human trabecular meshwork cells.
   PLoS One. 2019;14:e0221693.
   PubMed     Text format     Abstract available
   
   
   January 2018
9. WADUTHANTRI S, Zhou L, Chee SP
   Intra-cameral level of ganciclovir gel, 0.15% following topical application for cytomegalovirus anterior segment infection: A pilot study.
   PLoS One. 2018;13:e0191850.
   PubMed     Text format     Abstract available
   
   
   
10. KOLDEHOFF M, Lindemann M, Ross SR, Elmaagacli AH, et al
    Cytomegalovirus induces HLA-class-II-restricted alloreactivity in an acute myeloid leukemia cell line.
    PLoS One. 2018;13:e0191482.
    PubMed     Text format     Abstract available
    
    
    
11. STOCKDALE L, Nash S, Nalwoga A, Painter H, et al
    Human cytomegalovirus epidemiology and relationship to tuberculosis and cardiovascular disease risk factors in a rural Ugandan cohort.
    PLoS One. 2018;13:e0192086.
    PubMed     Text format     Abstract available
    
    
    
12. SCHLOTT F, Steubl D, Ameres S, Moosmann A, et al
    Characterization and clinical enrichment of HLA-C*07:02-restricted Cytomegalovirus-specific CD8+ T cells.
    PLoS One. 2018;13:e0193554.
    PubMed     Text format     Abstract available
    
    
    
13. DRABORG AH, Rasmussen NS, Larsen JL, Jorgensen CS, et al
    Immune responses to an early lytic cytomegalovirus antigen in systemic lupus erythematosus patients: T-cell responses, cytokine secretions and antibody status.
    PLoS One. 2018;13:e0193244.
    PubMed     Text format     Abstract available
    
    
    
14. MADRID L, Varo R, Maculuve S, Nhampossa T, et al
    Congenital cytomegalovirus, parvovirus and enterovirus infection in Mozambican newborns at birth: A cross-sectional survey.
    PLoS One. 2018;13:e0194186.
    PubMed     Text format     Abstract available
    
    
    
15. CHANOUZAS D, Small A, Borrows R, Ball S, et al
    Assessment of the T-SPOT.CMV interferon-gamma release assay in renal transplant recipients: A single center cohort study.
    PLoS One. 2018;13:e0193968.
    PubMed     Text format     Abstract available
    
    
    
16. GERGEN J, Coulon F, Creneguy A, Elain-Duret N, et al
    Multiplex CRISPR/Cas9 system impairs HCMV replication by excising an essential viral gene.
    PLoS One. 2018;13:e0192602.
    PubMed     Text format     Abstract available
    
    
    
17. IGLESIAS-ESCUDERO M, Moro-Garcia MA, Marcos-Fernandez R, Garcia-Torre A, et al
    Levels of anti-CMV antibodies are modulated by the frequency and intensity of virus reactivations in kidney transplant patients.
    PLoS One. 2018;13:e0194789.
    PubMed     Text format     Abstract available
    
    
    
18. GIMENO BRIAS S, Marsden M, Forbester J, Clement M, et al
    Interferon lambda is required for interferon gamma-expressing NK cell responses but does not afford antiviral protection during acute and persistent murine cytomegalovirus infection.
    PLoS One. 2018;13:e0197596.
    PubMed     Text format     Abstract available
    
    
    
19. ROVITO R, Warnatz HJ, Kielbasa SM, Mei H, et al
    Impact of congenital cytomegalovirus infection on transcriptomes from archived dried blood spots in relation to long-term clinical outcome.
    PLoS One. 2018;13:e0200652.
    PubMed     Text format     Abstract available
    
    
    
20. STRANG BL, Asquith CRM, Moshrif HF, Ho CM, et al
    Identification of lead anti-human cytomegalovirus compounds targeting MAP4K4 via machine learning analysis of kinase inhibitor screening data.
    PLoS One. 2018;13:e0201321.
    PubMed     Text format     Abstract available
    
    
    
21. WEHRENS EJ, Wong KA, Gupta A, Khan A, et al
    IL-27 regulates the number, function and cytotoxic program of antiviral CD4 T cells and promotes cytomegalovirus persistence.
    PLoS One. 2018;13:e0201249.
    PubMed     Text format     Abstract available
    
    
    
22. LACHMANN R, Loenenbach A, Waterboer T, Brenner N, et al
    Cytomegalovirus (CMV) seroprevalence in the adult population of Germany.
    PLoS One. 2018;13:e0200267.
    PubMed     Text format     Abstract available
    
    
    
23. ANNIBALI O, Piccioni L, Tomarchio V, Circhetta E, et al
    Impact of IFN lambda 3/4 single nucleotide polymorphisms on the cytomegalovirus reactivation in autologous stem cell transplant patients.
    PLoS One. 2018;13:e0200221.
    PubMed     Text format     Abstract available
    
    
    
24. NISBET AI, Omuse G, Revathi G, Adam RD, et al
    Seroprevalence data at a private teaching hospital in Kenya: An examination of Toxoplasma gondii, cytomegalovirus, rubella, hepatitis A, and Entamoeba histolytica.
    PLoS One. 2018;13:e0204867.
    PubMed     Text format     Abstract available
    
    
    
25. KAUR A, Itell HL, Ehlinger EP, Varner V, et al
    Natural history of postnatal rhesus cytomegalovirus shedding by dams and acquisition by infant rhesus monkeys.
    PLoS One. 2018;13:e0206330.
    PubMed     Text format     Abstract available
    
    
    
26. KAMTCHUM-TATUENE J, Al-Bayati Z, Mwandumba HC, Solomon T, et al
    Serum concentration of anti-Cytomegalovirus IgG and ischaemic stroke in patients with advanced HIV infection in Malawi.
    PLoS One. 2018;13:e0208040.
    PubMed     Text format     Abstract available
    
    
    
27. WIDMAN DG, Gornisiewicz S, Shacham S, Tamir S, et al
    In vitro toxicity and efficacy of verdinexor, an exportin 1 inhibitor, on opportunistic viruses affecting immunocompromised individuals.
    PLoS One. 2018;13:e0200043.
    PubMed     Text format     Abstract available
    
    
    January 2017
28. STUDZINSKA M, Jablonska A, Wisniewska-Ligier M, Nowakowska D, et al
    Association of TLR3 L412F Polymorphism with Cytomegalovirus Infection in Children.
    PLoS One. 2017;12:e0169420.
    PubMed     Text format     Abstract available
    
    
    
29. SCHLOTT F, Steubl D, Hoffmann D, Matevossian E, et al
    Primary Cytomegalovirus Infection in Seronegative Kidney Transplant Patients Is Associated with Protracted Cold Ischemic Time of Seropositive Donor Organs.
    PLoS One. 2017;12:e0171035.
    PubMed     Text format     Abstract available
    
    
    
30. ALSTON CI, Dix RD
    Murine cytomegalovirus infection of mouse macrophages stimulates early expression of suppressor of cytokine signaling (SOCS)1 and SOCS3.
    PLoS One. 2017;12:e0171812.
    PubMed     Text format     Abstract available
    
    
    
31. BOECK JM, Spencer JV
    Effect of human cytomegalovirus (HCMV) US27 on CXCR4 receptor internalization measured by fluorogen-activating protein (FAP) biosensors.
    PLoS One. 2017;12:e0172042.
    PubMed     Text format     Abstract available
    
    
    
32. GUO G, Zhang L, Ye S, Hu Y, et al
    Polymorphisms and features of cytomegalovirus UL144 and UL146 in congenitally infected neonates with hepatic involvement.
    PLoS One. 2017;12:e0171959.
    PubMed     Text format     Abstract available
    
    
    
33. OTGONJARGALA B, Becker K, Batbaatar G, Tsogtsaikhan S, et al
    Effect of Mycoplasma hominis and cytomegalovirus infection on pregnancy outcome: A prospective study of 200 Mongolian women and their newborns.
    PLoS One. 2017;12:e0173283.
    PubMed     Text format     Abstract available
    
    
    
34. LE-TRILLING VT, Trilling M
    Mouse newborn cells allow highly productive mouse cytomegalovirus replication, constituting a novel convenient primary cell culture system.
    PLoS One. 2017;12:e0174695.
    PubMed     Text format     Abstract available
    
    
    
35. GAN X, Wang H, Yu Y, Yi W, et al
    Epigenetically repressing human cytomegalovirus lytic infection and reactivation from latency in THP-1 model by targeting H3K9 and H3K27 histone demethylases.
    PLoS One. 2017;12:e0175390.
    PubMed     Text format     Abstract available
    
    
    
36. JIANG XJ, Zhang J, Xiong Y, Jahn G, et al
    Human cytomegalovirus glycoprotein polymorphisms and increasing viral load in AIDS patients.
    PLoS One. 2017;12:e0176160.
    PubMed     Text format     Abstract available
    
    
    
37. YANG CF, Ho HL, Lin SC, Hsu CY, et al
    Detection of human cytomegalovirus in glioblastoma among Taiwanese subjects.
    PLoS One. 2017;12:e0179366.
    PubMed     Text format     Abstract available
    
    
    
38. TOVAR-SALAZAR A, Weinberg A
    Cytomegalovirus infection in HIV-infected and uninfected individuals is characterized by circulating regulatory T cells of unconstrained antigenic specificity.
    PLoS One. 2017;12:e0180691.
    PubMed     Text format     Abstract available
    
    
    
39. THOMASINI RL, Pereira DS, Pereira FSM, Mateo EC, et al
    Aged-associated cytomegalovirus and Epstein-Barr virus reactivation and cytomegalovirus relationship with the frailty syndrome in older women.
    PLoS One. 2017;12:e0180841.
    PubMed     Text format     Abstract available
    
    
    
40. LEE KY, Yoo BW, Ahn SS, Bae WH, et al
    Predictors of mortality in autoimmune disease patients with concurrent cytomegalovirus infections detected by quantitative real-time PCR.
    PLoS One. 2017;12:e0181590.
    PubMed     Text format     Abstract available
    
    
    
41. HALL CE, Koparde VN, Jameson-Lee M, Elnasseh AG, et al
    Sequence homology between HLA-bound cytomegalovirus and human peptides: A potential trigger for alloreactivity.
    PLoS One. 2017;12:e0178763.
    PubMed     Text format     Abstract available
    
    
    
42. TOMINO A, Tsuda M, Aoki R, Kajita Y, et al
    Increased PD-1 Expression and Altered T Cell Repertoire Diversity Predict Mortality in Patients with Septic Shock: A Preliminary Study.
    PLoS One. 2017;12:e0169653.
    PubMed     Text format     Abstract available
    
    
    
43. CHIUPPESI F, Wussow F, Scharf L, Contreras H, et al
    Comparison of homologous and heterologous prime-boost vaccine approaches using Modified Vaccinia Ankara and soluble protein to induce neutralizing antibodies by the human cytomegalovirus pentamer complex in mice.
    PLoS One. 2017;12:e0183377.
    PubMed     Text format     Abstract available
    
    
    
44. BOOIMAN T, Wit FW, Girigorie AF, Maurer I, et al
    Terminal differentiation of T cells is strongly associated with CMV infection and increased in HIV-positive individuals on ART and lifestyle matched controls.
    PLoS One. 2017;12:e0183357.
    PubMed     Text format     Abstract available
    
    
    
45. MAIER AK, Jung R, Villinger C, Schubert A, et al
    A Luciferase Gene Driven by an Alphaherpesviral Promoter Also Responds to Immediate Early Antigens of the Betaherpesvirus HCMV, Allowing Comparative Analyses of Different Human Herpesviruses in One Reporter Cell Line.
    PLoS One. 2017;12:e0169580.
    PubMed     Text format     Abstract available
    
    
    
46. LI Z, Tang Y, Tang N, Feng Q, et al
    High anti-human cytomegalovirus antibody levels are associated with the progression of essential hypertension and target organ damage in Han Chinese population.
    PLoS One. 2017;12:e0181440.
    PubMed     Text format     Abstract available
    
    
    
47. OKAHARA K, Nagata N, Shimada T, Joya A, et al
    Colonic cytomegalovirus detection by mucosal PCR and antiviral therapy in ulcerative colitis.
    PLoS One. 2017;12:e0183951.
    PubMed     Text format     Abstract available
    
    
    
48. PICAT MQ, Pellegrin I, Bitard J, Wittkop L, et al
    Integrative Analysis of Immunological Data to Explore Chronic Immune T-Cell Activation in Successfully Treated HIV Patients.
    PLoS One. 2017;12:e0169164.
    PubMed     Text format     Abstract available
    
    
    
49. GOMEZ-MORA E, Massanella M, Garcia E, Giles D, et al
    Elevated humoral response to cytomegalovirus in HIV-infected individuals with poor CD4+ T-cell immune recovery.
    PLoS One. 2017;12:e0184433.
    PubMed     Text format     Abstract available
    
    
    
50. GRIFFITHS PD, Rothwell E, Raza M, Wilmore S, et al
    Correction: Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy.
    PLoS One. 2017;12:e0185298.
    PubMed     Text format     Abstract available
    
    
    
51. MULDOON KM, Armstrong-Heimsoth A, Thomas J
    Knowledge of congenital cytomegalovirus (cCMV) among physical and occupational therapists in the United States.
    PLoS One. 2017;12:e0185635.
    PubMed     Text format     Abstract available
    
    
    
52. EBADAT S, Ahmadi S, Ahmadi M, Nematpour F, et al
    Evaluating the efficiency of CHEF and CMV promoter with IRES and Furin/2A linker sequences for monoclonal antibody expression in CHO cells.
    PLoS One. 2017;12:e0185967.
    PubMed     Text format     Abstract available
    
    
    
53. SUN X, Chen W, He L, Sheng J, et al
    Inhibition of human cytomegalovirus immediate early gene expression and growth by a novel RNase P ribozyme variant.
    PLoS One. 2017;12:e0186791.
    PubMed     Text format     Abstract available
    
    
    
54. VISWANATHAN K, Verweij MC, John N, Malouli D, et al
    Quantitative membrane proteomics reveals a role for tetraspanin enriched microdomains during entry of human cytomegalovirus.
    PLoS One. 2017;12:e0187899.
    PubMed     Text format     Abstract available
    
    
    
55. MELE F, Fornara C, Jarrossay D, Furione M, et al
    Phenotype and specificity of T cells in primary human cytomegalovirus infection during pregnancy: IL-7Rpos long-term memory phenotype is associated with protection from vertical transmission.
    PLoS One. 2017;12:e0187731.
    PubMed     Text format     Abstract available
    
    
    
56. LEE H, Park KH, Ryu JH, Choi AR, et al
    Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients.
    PLoS One. 2017;12:e0189488.
    PubMed     Text format     Abstract available
    
    
    
57. MALIK A, Adland E, Laker L, Kloverpris H, et al
    Immunodominant cytomegalovirus-specific CD8+ T-cell responses in sub-Saharan African populations.
    PLoS One. 2017;12:e0189612.
    PubMed     Text format     Abstract available
    
    
    
58. ELDAR-YEDIDIA Y, Hillel M, Cohen A, Bar-Meir M, et al
    Association of toll-like receptors polymorphism and intrauterine transmission of cytomegalovirus.
    PLoS One. 2017;12:e0189921.
    PubMed     Text format     Abstract available
    
    
    January 2016
59. GRIFFITHS PD, Rothwell E, Raza M, Wilmore S, et al
    Randomized Controlled Trials to Define Viral Load Thresholds for Cytomegalovirus Pre-Emptive Therapy.
    PLoS One. 2016;11:e0163722.
    PubMed     Text format     Abstract available
    
    
    
60. DAVIS-POYNTER N, Yunis J, Farrell HE
    The Cytoplasmic C-Tail of the Mouse Cytomegalovirus 7 Transmembrane Receptor Homologue, M78, Regulates Endocytosis of the Receptor and Modulates Virus Replication in Different Cell Types.
    PLoS One. 2016;11:e0165066.
    PubMed     Text format     Abstract available
    
    
    
61. LIU Y, Chen AS, Kamphaengkham S, Leenasirimakul P, et al
    Diagnostic Utility of Ocular Symptoms and Vision for Cytomegalovirus Retinitis.
    PLoS One. 2016;11:e0165564.
    PubMed     Text format     Abstract available
    
    
    
62. POIZOT-MARTIN I, Allavena C, Duvivier C, Cano CE, et al
    CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART.
    PLoS One. 2016;11:e0165774.
    PubMed     Text format     Abstract available
    
    
    
63. TRGOVCICH J, Kincaid M, Thomas A, Griessl M, et al
    Cytomegalovirus Reinfections Stimulate CD8 T-Memory Inflation.
    PLoS One. 2016;11:e0167097.
    PubMed     Text format     Abstract available
    
    
    
64. REMIS RS, Liu J, Loutfy MR, Tharao W, et al
    Prevalence of Sexually Transmitted Viral and Bacterial Infections in HIV-Positive and HIV-Negative Men Who Have Sex with Men in Toronto.
    PLoS One. 2016;11:e0158090.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: